Recce eyes US Defence grants with early data for R327 on burn wounds
Recce Pharma (ASX:RCE) has notched modest gains in the Tuesday arvo session after reporting its R327 anti-infective gel...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
CNO | Form 603 Becoming a Substantial Holder 23 June 2011 | 23/06/11 | ||
CNO | Confirmation from Share Registry | 21/06/11 | ||
CNO | Updated Proforma Balance Sheet | 21/06/11 | ||
CNO | Terms of Options on Issue | 21/06/11 | ||
CNO | Updated statement of commitments | 21/06/11 | ||
CNO | Prequotation confirmations by Company | 21/06/11 | ||
CNO | Distribution Schedule | 21/06/11 | ||
CNO | Statement of Restricted Securities | 21/06/11 | ||
CNO | Top 20 Shareholders | 21/06/11 | ||
CNO | Corporate Governance Policy | 21/06/11 | ||
CNO | Share Trading Policy | 21/06/11 | ||
CNO | Constitution | 21/06/11 | ||
CNO | Appendix 1A - ASX Listing application and agreement | 21/06/11 | ||
CNO | ASX Circular - Commencement of Official Quotation | 21/06/11 | ||
CNO | Pre Quotation Disclosure | 21/06/11 | ||
CNO | Admission to Official List | PRICE SENSITIVE | 21/06/11 | |
CNO | Disclosure Document | 29/04/11 | ||